Management of Low-Dose Aspirin Before Cesarean Section
For pregnant women taking low-dose aspirin 75 mg who are undergoing elective cesarean section, aspirin should be stopped 1-2 weeks prior to delivery to minimize bleeding risk, particularly in the context of neuraxial anesthesia.
Clinical Context and Rationale
The decision to discontinue aspirin before cesarean section must balance two competing risks: thrombotic complications versus perioperative bleeding. The evidence base addresses this primarily in two clinical scenarios:
For Women with Myeloproliferative Neoplasms
- Aspirin should be discontinued one week prior to surgical procedures and restarted 24 hours after surgery or when considered acceptable depending on bleeding risk 1.
- For pregnancy specifically in this population, consider stopping low-dose aspirin 1 to 2 weeks prior to delivery 1.
For General Obstetric Population on Aspirin for Preeclampsia Prevention
- The American College of Chest Physicians guidelines for lactating women using low-dose aspirin for vascular indications suggest continuing this medication during breastfeeding, but do not provide specific guidance on perioperative management for cesarean section 2.
- Low-dose aspirin (75-100 mg) in the second and third trimesters is reasonable in addition to anticoagulation in patients with mechanical prosthetic valves, but specific cesarean section timing is not addressed 3.
Bleeding Risk Considerations
Evidence on Bleeding Complications
- Recent research suggests that aspirin recommendation in pregnancy was associated with increased risk for placental abruption (adjusted OR 1.44,95% CI 1.04-2.00) and postpartum hemorrhage (adjusted OR 1.21,95% CI 1.05-1.39) 4.
- The number needed to harm with low-dose aspirin was 79 for postpartum hemorrhage and 287 for placental abruption 4.
- However, other studies found that preconception-initiated daily low-dose aspirin was not associated with increased bleeding risk and showed no increased risk of bleeding complications 5, 6.
Neuraxial Anesthesia Timing
While the evidence provided focuses on LMWH timing rather than aspirin specifically, the principles of neuraxial safety are relevant:
- Prophylactic anticoagulation should be timed carefully around neuraxial procedures to minimize bleeding complications 7.
- The concern for epidural hematoma necessitates careful timing of antiplatelet agents before cesarean section with planned neuraxial anesthesia.
Practical Algorithm for Aspirin Management
Step 1: Assess Indication for Aspirin
- Preeclampsia prevention: Most common indication for low-dose aspirin in pregnancy 8, 9.
- Myeloproliferative disorders: Requires specific management per hematology guidelines 1.
- Mechanical heart valves or other thrombotic conditions: May require alternative anticoagulation 3.
Step 2: Timing of Discontinuation
- For elective cesarean section: Stop aspirin 1-2 weeks before scheduled delivery 1.
- This timing allows for normalization of platelet function (aspirin's effect lasts the lifespan of platelets, approximately 7-10 days).
Step 3: Consider Alternative Thromboprophylaxis
- If high thrombotic risk persists, consider switching to LMWH in the last two weeks of pregnancy 1.
- LMWH can be stopped 12-24 hours before expected labor or cesarean section, providing more precise control of anticoagulation 1.
Step 4: Postoperative Management
- Restart aspirin 24 hours after surgery or when bleeding risk is acceptable 1.
- For women who underwent cesarean section and have persistent high-risk factors, consider extended thromboprophylaxis with LMWH for up to 6 weeks postpartum 2, 7.
Important Caveats
Risk Stratification for VTE After Cesarean Section
- Women undergoing cesarean section without additional thrombosis risk factors do not require thromboprophylaxis other than early mobilization 2.
- Women at increased risk due to one major or at least two minor risk factors should receive pharmacologic thromboprophylaxis (prophylactic LMWH) or mechanical prophylaxis while in hospital following delivery 2.
Aspirin Dose Considerations
- The evidence shows no significant difference in preeclampsia incidence or bleeding complications between 150-160 mg versus 75 mg aspirin during pregnancy 10.
- Aspirin doses ≥100 mg were more effective in reducing preterm preeclampsia risk compared to doses <100 mg 11.
FDA Labeling Warnings
- Aspirin use during the last 3 months of pregnancy should only be under physician direction due to potential problems in the unborn child or complications during delivery 12.
- The FDA label warns about increased stomach bleeding risk, particularly in patients age 60 or older, those with prior ulcers, those taking anticoagulants, and those consuming 3 or more alcoholic drinks daily 12.